Local Thrombolytics Before Thrombectomy in STEMI (DISSOLUTION)
Local Delivery of thrombolytIcs Before Thrombectomy in patientS With ST-elevatiOn myocardiaL Infarction Undergoing Primary percuTaneous Coronary interventION - The DISSOLUTION Randomized Trial
Sponsor: University of Roma La Sapienza
This PHASE4 trial investigates Coronary Artery Disease and is currently ongoing. University of Roma La Sapienza leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Enrolling By Invitation PHASE4
-
May 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE4
▶ Show 4 earlier versions
-
Apr 2020 — May 2020 [monthly]
Enrolling By Invitation PHASE4
Status: Unknown Status → Enrolling By Invitation
-
Jun 2018 — Apr 2020 [monthly]
Unknown Status PHASE4
-
May 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Roma La Sapienza
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.